Evidence map›Paper›PMID 35613752›Full record

SynthesisBMJ open2022

Effect of routinely assessing and addressing depression and diabetes distress on clinical outcomes among adults with type 2 diabetes: a systematic review.

Rita McMorrow, Barbara Hunter, Christel Hendrieckx, Dominika Kwasnicka, Jane Speight, Leanne Cussen, Felicia Ching Siew Ho, Jon Emery, Jo-Anne Manski-Nankervis

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rita McMorrowDepartment of General Practice, The University of Melbourne, Melbourne, Victoria, Australia rita.mcmorrow@unimelb.edu.au.ORCID 0000-0002-2835-9504
Barbara HunterDepartment of General Practice, The University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-1268-3166
Christel HendrieckxThe Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, Victoria, Australia.
Dominika KwasnickaNHMRC CRE in Digital Technology to Transform Chronic Disease Outcomes, The Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Jane SpeightThe Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, Victoria, Australia.
Leanne CussenDepartment of Endocrinology, Beaumont Hospital, Dublin, Ireland.
Felicia Ching Siew HoMelbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.
Jon EmeryDepartment of General Practice, The University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-5274-6336
Jo-Anne Manski-NankervisDepartment of General Practice, The University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0003-2153-3482

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study examined the effect of using patient-reported outcome measures (PROMs) routinely to assess and address depressive symptoms and diabetes distress among adults with type 2 diabetes.

designA systematic review of published peer-reviewed studies. DATA SOURCES: Medline, Embase, CINAHL Complete, PsycINFO, The Cochrane Library and Cochrane Central Register of Controlled Trials were searched. ELIGIBILITY CRITERIA: Studies including adults with type 2 diabetes, published in English, from the inception of the databases to 24 February 2022 inclusive; and where the intervention included completion of a PROM of depressive symptoms and/or diabetes distress, with feedback of the responses to a healthcare professional. DATA EXTRACTION AND SYNTHESIS: Using Covidence software, screening and risk of bias assessment were conducted by two reviewers independently with any disagreements resolved by a third reviewer.

resultsThe search identified 4512 citations, of which 163 full-text citations were assessed for eligibility, and nine studies met the inclusion criteria. Five studies involved assessment of depressive symptoms only, two studies assessed diabetes distress only, and two studies assessed both. All studies had an associated cointervention. When depressive symptoms were assessed (n=7), a statistically significant between-group difference in depressive symptoms was observed in five studies; with a clinically significant (

conclusionStudies are sparse in which PROMs are used to assess and address depressive symptoms or diabetes distress during routine clinical care of adults with type 2 diabetes. Further research is warranted to understand how to integrate PROMs into clinical care efficiently and determine appropriate interventions to manage identified problem areas. PROSPERO REGISTRATION NUMBER: CRD42020200246.

Indexed as

Diabetes Mellitus, Type 2Text MessagingAdultDepressionGlycated HemoglobinHumansGlycated Hemoglobin%20Type%202">Diabetes MellitusDepressionPatient Reported Outcome MeasuresType 2

Identifiers

PMID35613752
PMCPMC9134162

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.